|
1
|
Lackland DT, Roccella EJ, Deutsch AF,
Fornage M, George MG, Howard G, Kissela BM, Kittner SJ, Lichtman
JH, Lisabeth LD, et al: American Heart Association Stroke Council;
Council on Cardiovascular and Stroke Nursing: Council on Quality of
Care and Outcomes Research; Council on Functional Genomics and
Translational Biology: Factors influencing the decline in stroke
mortality: A statement from the American Heart Association/American
Stroke Association. Stroke. 45:315–353. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bhaskar S, Stanwell P, Cordato D, Attia J
and Levi C: Reperfusion therapy in acute ischemic stroke: Dawn of a
new era? BMC Neurol. 18:82018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu D, Tang ZY, Hu ZJ, Li WW and Yuan WN:
MiR-940 regulates angiogenesis after cerebral infarction through
VEGF. Eur Rev Med Pharmacol Sci. 22:7899–7907. 2018.PubMed/NCBI
|
|
4
|
Lin MP, Sanossian N and Liebeskind DS:
Imaging of prehospital stroke therapeutics. Expert Rev Cardiovasc
Ther. 13:1001–1015. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McCulloch L, Smith CJ and McColl BW:
Adrenergic-mediated loss of splenic marginal zone B cells
contributes to infection susceptibility after stroke. Nat Commun.
8:150512017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gulli G, Rutten-Jacobs LC, Kalra L, Rudd
AG, Wolfe CD and Markus HS: Differences in the distribution of
stroke subtypes in a UK black stroke population - final results
from the South London Ethnicity and Stroke Study. BMC Med.
14:772016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Weiss CN and Ito K: A Macro View of
MicroRNAs: The discovery of microRNAs and their role in
hematopoiesis and hematologic disease. Int Rev Cell Mol Biol.
334:99–175. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soares RJ, Cagnin S, Chemello F,
Silvestrin M, Musaro A, De Pitta C, Lanfranchi G and Sandri M:
Involvement of microRNAs in the regulation of muscle wasting during
catabolic conditions. J Biol Chem. 289:21909–21925. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan JR, Tan KS, Yong FL, Armugam A, Wang
CW, Jeyaseelan K and Wong PT: MicroRNAs regulating cluster of
differentiation 46 (CD46) in cardioembolic and non-cardioembolic
stroke. PLoS One. 12:e01721312017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ding C, Chen SN, Macleod RAF, Drexler HG,
Nagel S, Wu DP, Sun AN and Dai HP: MiR-130a is aberrantly
overexpressed in adult acute myeloid leukemia with t(8;21) and its
suppression induces AML cell death. Ups J Med Sci. 123:19–27. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu G, Zhang W, Liu Y and Wang S: miR 371b
5p inhibits endothelial cell apoptosis in monocrotaline induced
pulmonary arterial hypertension via PTEN/PI3K/Akt signaling
pathways. Mol Med Rep. 18:5489–5501. 2018.PubMed/NCBI
|
|
12
|
Rothwell PM, Algra A, Chen Z, Diener HC,
Norrving B and Mehta Z: Effects of aspirin on risk and severity of
early recurrent stroke after transient ischaemic attack and
ischaemic stroke: Time-course analysis of randomised trials.
Lancet. 388:365–375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lamontagne J, Steel LF and Bouchard MJ:
Hepatitis B virus and microRNAs: Complex interactions affecting
hepatitis B virus replication and hepatitis B virus-associated
diseases. World J Gastroenterol. 21:7375–7399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Selvamani A, Williams MH, Miranda RC and
Sohrabji F: Circulating miRNA profiles provide a biomarker for
severity of stroke outcomes associated with age and sex in a rat
model. Clin Sci (Lond). 127:77–89. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang H, Yu WW, Wang LL and Peng Y:
miR-130a acts as a potential diagnostic biomarker and promotes
gastric cancer migration, invasion and proliferation by targeting
RUNX3. Oncol Rep. 34:1153–1161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Chen M, Qiu Z, Hu K, McGee W,
Chen X, Liu J, Zhu L and Wu JY: MiR-130a regulates neurite
outgrowth and dendritic spine density by targeting MeCP2. Protein
Cell. 7:489–500. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Altintas O, Ozgen Altintas M, Kumas M and
Asil T: Neuroprotective effect of ischemic preconditioning via
modulating the expression of cerebral miRNAs against transient
cerebral ischemia in diabetic rats. Neurol Res. 38:1003–1011. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Y, Qiu S, Qian L, Tian Y, Chen Y, Bi
L and Chen W: OCF can repress tumor metastasis by inhibiting
epithelial-mesenchymal transition involved in PTEN/PI3K/AKT pathway
in lung cancer cells. PLoS One. 12:e01740212017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han M, Chen L and Wang Y: miR-218
overexpression suppresses tumorigenesis of papillary thyroid cancer
via inactivation of PTEN/PI3K/AKT pathway by targeting Runx2.
OncoTargets Ther. 11:6305–6316. 2018. View Article : Google Scholar
|
|
20
|
Chang M, Wu M and Li H: Curcumin combined
with glycyrrhetinic acid inhibits the development of hepatocellular
carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling
pathway. Am J Transl Res. 9:5567–5575. 2017.PubMed/NCBI
|
|
21
|
Acosta SA, Tajiri N, Hoover J, Kaneko Y
and Borlongan CV: Intravenous bone marrow stem cell grafts
preferentially migrate to spleen and abrogate chronic inflammation
in stroke. Stroke. 46:2616–2627. 2015. View Article : Google Scholar : PubMed/NCBI
|
